BioElectronics CorpOOTC BIEL Stock Report

BioElectronics Corp. engages in the development of wearable, nueromodulation devices for diabetic neuropathy, postoperative surgery, chronic wounds, and other applications. The company is headquartered in Frederick, Maryland. The company went IPO on 2004-04-12. The firm develops wearable, neuromodulation devices to mitigate neurological diseases. The devices are used to treat acute and chronic pain as well as to promote wound healing. Its pulsed shortwave therapy technology (PSWT) that uses low power pulsed electromagnetic fields regulates electrical activity of the nervous system. Its product line includes ActiPatch Musculoskeletal Pain Therapy, Allay Menstrual Pain Therapy, Smart Insole Heel Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy. Its flagship product, the ActiPatch Musculoskeletal Pain Therapy is developed to relieve chronic pain. ActiPatch is a drug-free, wearable nonprescription medical device that provides about 720-hours of on/off therapy. The company provides extended duration treatments and hospital and safe home use therapy to help self-management of pain. The firm is focused on international customers to expand its distribution and sales.